• Home
  • Search
  • Insulin Analog with Additional Disulfide Bond Forms a Structurally Secure, Thermodynamically Stable Molecule
  • https://doi.org/10.1096/fasebj.2020.34.s1.09589Copy DOI Icon

Insulin Analog with Additional Disulfide Bond Forms a Structurally Secure, Thermodynamically Stable Molecule

Show More
  • Abstract
  • Literature Map
  • References
  • Similar Papers
Abstract

Insulin is a hormone secreted by the pancreatic cells. In vivo, normal insulin contains 3 disulfide bonds that account for structural instability and low melting point. In this experiment, an insulin analog was attempted to be made mechanically and thermodynamically more stable than human insulin (HI). It was hypothesized that the addition of a fourth disulfide bond (4SS‐insulin) would be more stable as previous attempts at other types of transformational change to the A‐chain and B‐chain were unsuccessful. By adding a fourth disulfide bond in positions A10/B4, the outcome would be a significant clinical application for the treatment of insulin‐dependent diabetes as scientists are constantly trying to find insulin analogs that would potentiate the effects of blood sugar lowering. To experiment, the fourth disulfide bond was successfully formed using yeast as a template. They tested fragility (fibrillation), low pH, and thermodynamic stabilization, finding that the fourth disulfide bond made insulin more mechanically and thermodynamically stable. Once this was complete, in vivo experimentation on rates demonstrated the effect on blood glucose and in vitro experimentation on lipogenesis in rat adipocytes. In vivo, 4SS‐insulin had a longer and more profound effect on blood glucose than HI. In vitro, 4SS‐insulin had a greater affinity for insulin receptors than HI. The Kohler High School MAPS Team used 3‐D modeling and printing technology to examine the relationship between a structurally secure fourth disulfide bond and the thermodynamic stability of an insulin analog in comparison to typical HI. The clinical applicability of this new biomedically engineered 4SS‐insulin is significant. Patients could be able to self‐inject less insulin less frequently, helping with affordability and improved glycemic control. Additionally, the storage of insulin becomes more convenient as 4SS‐insulin can withstand a 34.6 °Celsius increase in melting temperature. PDB: 4EFX

Similar Papers
  • Discussion
  • Citations4

Commentary: Politics of affordable insulin

  • Sep 14, 2011
  • BMJ
  • E A M Gale +1
  • Research Article
  • Citations6

Polar Plasmodium falciparum lipids induce lipogenesis in rat adipocytes in vitro

  • Dec 01, 2000
  • Microbes and Infection
  • Sedigheh Zakeri +3
  • PDF
  • Research Article
  • Citations6

Use of Analog and Human Insulin in a European Hemodialysis Cohort With Type 2 Diabetes: Associations With Mortality, Hospitalization, MACE, and Hypoglycemia

  • Aug 30, 2023
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Thomas Ebert +10
  • Research Article
  • Citations7

Non-glycemic effects of insulin therapy: a comparison between insulin aspart and regular human insulin during two consecutive meals in patients with type 2 diabetes

  • May 23, 2011
  • European Journal of Endocrinology
  • H Sourij +8
  • Research Article
  • Citations141

Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling

  • Apr 28, 2010
  • Diabetologia
  • L Sciacca +6
  • Research Article
  • Citations151

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.

  • Jul 01, 1996
  • Diabetic Medicine
  • L Heinemann +6
  • Research Article
  • Citations27

Counterregulatory hormone release after human and porcine insulin in healthy subjects and patients with pituitary disorders

  • Jul 01, 1984
  • Klinische Wochenschrift
  • M M C Landgraf-Leurs +4
  • PDF
  • Research Article
  • Citations19

A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design

  • Jun 22, 2012
  • BMC Endocrine Disorders
  • Peter Lommer Kristensen +9
  • PDF
  • Research Article
  • Citations43

Structural Integrity of the B24 Site in Human Insulin Is Important for Hormone Functionality

  • Apr 01, 2013
  • Journal of Biological Chemistry
  • Lenka Žáková +7
  • Research Article
  • Citations79

Insulin analogs-are they worth it? Yes!

  • May 10, 2014
  • Diabetes Care
  • George Grunberger
  • Research Article
  • Citations6

Do the benefits of analog insulins justify their costs?

  • May 01, 2012
  • Diabetes Management
  • Sarah E Holden +1
  • Research Article
  • Citations111

The Long Acting Human Insulin Analog HOE 901: Characteristics of Insulin Signalling in Comparison to Asp(B10) and Regular Insulin

  • Mar 01, 1998
  • Hormone and Metabolic Research
  • L Berti +5
  • Research Article
  • Citations129

Insulin prices, availability and affordability in 13 low-income and middle-income countries

  • Jun 01, 2019
  • BMJ Global Health
  • Margaret Ewen +3
  • Research Article
  • Citations1

The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy

  • Jan 01, 2020
  • The Medical Bulletin of Sisli Etfal Hospital
  • Yuksel Asli Ozturkmen +7
  • Research Article
  • Citations623

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

  • Jun 30, 2009
  • Diabetologia
  • L G Hemkens +6
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.